Henshaw Capital’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
HRCM
NAMI
FLAM
CIP
Henshaw Capital's ATRC Position: Q4 2025 in Review
Henshaw Capital sold out of AtriCure (ATRC) in Q4 2025, closing a stake of 15,560 shares — an estimated $548K sold.
Henshaw Capital first reported a position in ATRC in Q1 2021 and held it in 19 quarters. The position peaked at $626K in Q2 2025. 233 funds tracked by Wall St. Rank hold ATRC as of Q4 2025.
- Henshaw Capital reported no remaining AtriCure position as of Q4 2025 after selling out during the quarter.
- Henshaw Capital sold 15,560 AtriCure shares in Q4 2025, an estimated $548K.
- Henshaw Capital first reported a position in AtriCure in Q1 2021 and held it in 19 quarters.
- Henshaw Capital's AtriCure position peaked at $626K in Q2 2025.
- 233 funds tracked by Wall St. Rank held AtriCure as of Q4 2025.
Based on Henshaw Capital's 13F filing for Q4 2025, filed 28 May 2026.